This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Prior authorization is required for over 70% of imaging services for cancer care, according to survey findings published October 18 in JAMA Network Open. A team led by Fumiko Chino, MD, from the Memorial Sloan Kettering Cancer Center in New York, also found that prior authorization led to 22% of patients not receiving the care recommended by their treatment team and that most respondents experienced a delay in recommended oncology care.
A team of UC Davis scientists has used dynamic total-body positron emission tomography (PET) to provide the first imaging of the human body's immune response to COVID-19 infection in recovering patients. Their work, published in Science Advances, could lead to a better understanding of how the body's immune system responds to viral infections and develops long-term protection against re-infection.
Radiology technology company NewVue has launched EmpowerSuite, a PACS-integrated digital radiologist command center that uses AI to summarize clinical data and balance radiologists’ reading preferences with workload demand. The AI used in the command center aims to centralize and summarize patient data from disparate systems, including output from AI algorithms, the company said.
milla1cf Thu, 10/19/2023 - 17:53 October 19, 2023 — Alexandra Touroutoglou, PhD, and Bradford Dickerson, MD, neuroscientists in the department of Neurology at Massachusetts General Hospital, are the lead authors of a new study published in Alzheimer’s & Dementia , The Sporadic Early-onset Alzheimer’s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cohort.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Oxipit will deploy its latest AI quality assurance tool for CT pulmonary embolism (PE) at the Leiden University Medical Center (LUMC) in the Netherlands, expanding cooperation between the two entities. This latest deployment was facilitated through the radiology imaging product by Sectra and its integration capabilities. The medical center is already using the full suite of Oxipit AI products, including quality assurance tools for other modalities.
milla1cf Thu, 10/19/2023 - 17:48 October 19, 2023 — The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of many cell types in the lung, causing acute and sustained inflammation, and in the longer term, the thickening and scarring of lung tissue known as fibrosis.
milla1cf Thu, 10/19/2023 - 17:48 October 19, 2023 — The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of many cell types in the lung, causing acute and sustained inflammation, and in the longer term, the thickening and scarring of lung tissue known as fibrosis.
GE HealthCare is collaborating with Novo Nordisk to further advance the clinical and product development of peripheral-focused ultrasound (PFUS) to treat type 2 diabetes and obesity. PFUS is a non-invasive type of bioelectronic medicine that uses ultrasound to activate the nervous system to stimulate a response that may be able to treat disease. Previous reports suggest that it could impact glucose metabolism in people with diabetes through personalized ultrasound stimulation of nerve pathways.
milla1cf Thu, 10/19/2023 - 17:58 October 19, 2023 — A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer. To date, researchers have struggled to determine any risk factors that could shed light on who might experience these types of side effects ahead of time.
A non-invasive personalized cardiac test has demonstrated its capability to considerably reduce cardiovascular mortality and additional non-invasive heart testing while.
In a newly published literature review, researchers examined the benefits of diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) for breast cancer characterization and monitoring of neoadjuvant chemotherapy, current drawbacks that thwart wider adoption, and emerging techniques that may enhance the modality’s effectiveness.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
The development of tumors begins with miniscule changes within the body's cells; ion diffusion at the smallest scales is decisive in the performance of batteries. Until now the resolution of conventional imaging methods has not been high enough to represent these processes in detail. A research team has now developed diamond quantum sensors which can be used to improve resolution in magnetic imaging.
christine.book Thu, 10/19/2023 - 16:56 October 19, 2023 — NewVue, Inc. , in seeking to address the medical imaging community’s growing radiologist shortage and high-stress culture, has announced the unveiling of EmpowerSuite. In a written statement detailing the launch, the radiology workflow technology company noted that its revolutionary PACS -integrated digital radiologist command center supports radiologists by enhancing workflow efficiencies and job satisfaction.
Recruiting and data: A match made in business heaven. Your recruitment strategy has to deal with the fact that most job-seeking is now done online and across diverse platforms. Having the right data means you can streamline your recruitment efforts, align your talent searches with your organizational goals, and make the whole process vastly more cost-effective.
Mobile 1.5T system brings high-quality diagnostic imaging to offsite locations Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the MAGNETOM Viato.Mobile , a new 1.5 Tesla (1.5T) magnetic resonance (MR) imaging scanner optimized for mobile use to provide greater flexibility in deploying MR imaging.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
This study aimed to report the outcomes of the IN.DEPT trial assessing the feasibility, preliminary safety data, and 12-month outcomes of a new drug-coated balloon product for peripheral artery disease (PAD) in Chinese patients.
To evaluate the safety and effectiveness of ablative radioembolization for large hepatocellular carcinoma (HCC) while preserving a small future liver remnant (FLR).
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
299 
Let's personalize your content